CXCL8 and neoplasm: Additionally, the combination of cisplatin and irinotecan enhances the secretion of IL‐1β, IL‐8 and CXCL10 through the cGAS pathway, which promotes the infiltration of CD8+ T cells and dendritic cells, effectively inhibiting tumour growth.25